News
Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...
United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...
Doses of imported nine-valent human papillomavirus (HPV) vaccine were administered to male recipients in central ...
Biopharma giant MSD has received approval for its nine-valent HPV (human papillomavirus) vaccine for use in males aged ...
A class action lawsuit was filed against Merck & Co. (MRK) by Levi & Korsinsky on February 12, 2025. The plaintiffs ...
Recent market volatility notwithstanding, equities generally deliver solid returns over long periods, like a decade. The key is to purchase shares of robust companies, occasionally adding more, and to ...
Multinational companies in China’s vaccine market face headwinds amid an anti-corruption crackdown and rising competition.
The Iowa Senate advanced a bill Monday that would remove a minor's ability to consent to receiving an HPV vaccine.
Merck has a strong vaccine business, thanks to the human papillomavirus (HPV) products Gardasil and Gardasil 9. It's also a leader in the animal health business. However, its shares underperformed ...
A minor’s ability to legally consent on their own to receiving the HPV vaccine would be removed under legislation passed by the Iowa Senate Monday. Critics argue the bill will contribute to Iowa’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results